In future studies, it will be important to determine the effect of cellular sources of FABP4 on the pathogenesis of conditions such as cancer, obesity, and cardiovascular disease, where its circulating levels are regulated and known to be critical for systemic disease. This evidence concerns the gene FABP4 and obesity due to melanocortin 4 receptor deficiency.